LSD biotech MindMed buys digital trial firm HealthMode

LSD biotech MindMed buys digital trial firm HealthMode

Source: 
Pharmaforum
snippet: 

Psychedelic medicine biotech MindMed is to acquire digital medicine and therapeutics startup HealthMode for around $32.2 million, which uses artificial intelligence (AI) technology to speed up drug development.